where to pin cjc 1295 ipamorelin Inject Ipamorelin: Our Team's Expert Take CJC-1295 / Ipamorelin Peptide Therapy:

Phase IIb study of intranasal glutathione in Parkinson's disease

For skin, it inhibits tyrosinase, the enzyme that catalyzes melanin production

Monitor how your body responds, especially during the first 24 weeks of use

Trial evidence: Tesamorelin 2mg SC daily sustained GH/IGF-1 elevation, 15-18% visceral fat reduction over 6 months (Falutz, NEJM 2007, PMID 17699044) Ipamorelin 200-300 mcg peak GH 5-10x baseline within 30 minutes, no cortisol/prolactin bump (Raun, EJE 1998, PMID 9539826) GHRH + GHRP synergy 2-3x greater amplitude than either alone (Bowers, JCEM 1991, PMID 2004615) Community protocols extend this evidence base with cycling patterns that weren't studied in the original trials the 5-on/2-off rhythm and 8-week cycles are empirical community consensus, not clinically validated

Ipamorelin is a selective Ghrelin receptor agonist that mimics ghrelin to stimulate the release of growth hormone from the pituitary gland

DHA is essential for male fertility